Astec LifeSciences Ltd posts consolidated Q1FY24 loss of Rs. 8.19 crore

Astec LifeSciences Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 144.5572 crores during the period ended June 30, 2023 as compared to Rs. 129.5469 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. -8.1946 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. -4.9833 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. -4.18 for the period ended June 30, 2023 as compared to Rs. -2.54 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 144.5572 crs	₹129.5469 crs	11.59%
Net Profit	₹-8.1946 crs	₹-4.9833 crs	64.44%
EPS	₹-4.18	₹-2.54	64.57%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 144.5572 crores during the period ended June 30, 2023 as compared to Rs.186.9767 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.-8.1946 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.11.3999 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.-4.18 for the period ended June 30, 2023 as compared to Rs.5.81 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 144.5572 crs	₹186.9767 crs	-22.69%
Net Profit	₹-8.1946 crs	₹11.3999 crs	-171.88%
EPS	₹-4.18	₹5.81	-171.94%

Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 1229.45 as compared to the previous close of Rs. 1248.35. The total number of shares traded during the day was 3034 in over 857 trades.

The stock hit an intraday high of Rs. 1298.00 and intraday low of 1202.00. The net turnover during the day was Rs. 3751867.00.

Source : Equity Bulls

Keywords

AstecLifeSciences Q1FY24 ResultUpdate